American Portfolios Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

American Portfolios Advisors’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-200	Closed	-$78	–	2926
2020 Q1	$78	Hold	200	–	–	﹤0.01%	2749
2019 Q4	$82	Hold	200	–	–	﹤0.01%	2801
2019 Q3	$400	Hold	200	–	–	﹤0.01%	2731
2019 Q2	$432	Hold	200	–	–	﹤0.01%	2659
2019 Q1	$632	Hold	200	–	–	﹤0.01%	2511
2018 Q4	$498	Hold	200	–	–	﹤0.01%	2310
2018 Q3	$804	Hold	200	–	–	﹤0.01%	2319
2018 Q2	$756	Hold	200	–	–	﹤0.01%	2292
2018 Q1	$464	Hold	200	–	–	﹤0.01%	2245
2017 Q4	$310	Buy	+200	New	+$321	﹤0.01%	2212

American Portfolios Advisors's CORV Position: Q2 2020 in Review

American Portfolios Advisors sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 200 shares — an estimated $78 sold.

American Portfolios Advisors first reported a position in CORV in Q4 2017 and held it in 10 quarters. The position peaked at $804 in Q3 2018. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

American Portfolios Advisors reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
American Portfolios Advisors sold 200 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $78.
American Portfolios Advisors first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2017 and held it in 10 quarters.
American Portfolios Advisors's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $804 in Q3 2018.
0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on American Portfolios Advisors's 13F filing for Q2 2020, filed 24 Mar 2023.